8190sek
-1,3 %
Date:2025-06-04Time:18:00:00Latest report:Q4-2025List:Small CapTicker:EQL
Market Cap:2 380 msekEnterprise Value:2 749 msekNet Sales:373,5 msekEarnings:43,1 msekEmployees:0ISIN:SE0005497732

Ratios

10-year key figure history for EQL Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for EQL Pharma with index and moving average MA50 and MA200.

Stockprice:81,90
MA50:78,15
MA200:71,87
Price/MA200:13,9 %
RSI (14):49,4
Price/MA50:4,8 %

Description

EQL Pharma operates in the pharmaceutical industry and focuses on the development, manufacturing and distribution of generic medicines. The company's products are aimed at healthcare institutions and patients who need cost-effective treatment options. The business is global with a primary presence in Europe, North America and Asia. EQL Pharma was founded in 2006 and is headquartered in Lund, Sweden.

Pharmaceuticals